503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-25.99%
Both yoy net incomes decline, with CORZ at -261.32%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
161.11%
Some D&A expansion while CORZ is negative at -4.12%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-529.41%
Negative yoy deferred tax while CORZ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
11.98%
Less SBC growth vs. CORZ's 49.34%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
319.74%
Well above CORZ's 503.41% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
171.60%
AR growth is negative or stable vs. CORZ's 382766.67%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
124.68%
Growth well above CORZ's 156.60%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-159.56%
Negative yoy while CORZ is 221.96%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
38.24%
Operating cash flow growth below 50% of CORZ's 183.75%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-15.34%
Both yoy lines negative, with CORZ at -37.16%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1000.00%
Negative yoy acquisition while CORZ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
17.71%
Less growth in investment purchases vs. CORZ's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-69.05%
We reduce yoy sales while CORZ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-104.84%
Both yoy lines negative, with CORZ at -27.98%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-55.47%
Negative yoy issuance while CORZ is 36.84%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-150.46%
We cut yoy buybacks while CORZ is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.